Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System Read More > December 1, 2020
Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies – PubMed Read More > November 1, 2020
Ido Hartogsohn on the influence of society on the psychedelic experience Read More > September 8, 2020
